These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17003329)

  • 1. Antihypertensive medications and the risk of incident type 2 diabetes: response to Taylor et al.
    Gosmanov AR; Connelly S; Lewis JB; Gosmanov NR
    Diabetes Care; 2006 Oct; 29(10):2334; author reply 2334-5. PubMed ID: 17003329
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive therapy and the risk of type 2 diabetes mellitus.
    Sowers JR; Bakris GL
    N Engl J Med; 2000 Mar; 342(13):969-70. PubMed ID: 10738057
    [No Abstract]   [Full Text] [Related]  

  • 3. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
    Hilgers KF; Mann JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypertension therapy for type 2 diabetics].
    Bönner G
    MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579
    [No Abstract]   [Full Text] [Related]  

  • 5. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive medications and risk of diabetes mellitus.
    Barzilay JI; Cutler JA; Davis BR
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):256-60. PubMed ID: 17420670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension medication and periodontosis.
    Bowell GR
    Aust Dent J; 1997 Apr; 42(2):140. PubMed ID: 9153848
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of antihypertensive drugs and risk of cancer.
    Assimes TL; Elstein E; Langleben A; Suissa S
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1039-49. PubMed ID: 18780400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of type 2 diabetes mellitus with antihypertensive drugs.
    Nilsson PM; Cifkova R; Kjeldsen SE; Mancia G
    Blood Press; 2006; 15(4):253-4. PubMed ID: 17078188
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive therapy and incidence of type 2 diabetes in an elderly cohort: response to Padwal et al.
    Chan NN; Tong PC; Kong AP; Chan WB; Chan JC
    Diabetes Care; 2005 Mar; 28(3):762; author reply 762-3. PubMed ID: 15735235
    [No Abstract]   [Full Text] [Related]  

  • 15. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
    Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
    J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vascular agents can prevent type 2 diabetes].
    Nilsson P
    Lakartidningen; 2003 Feb; 100(7):528-30. PubMed ID: 12640987
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of new-onset diabetes mellitus in patients with hypertension treated with beta blockers.
    Ram CV
    Am J Cardiol; 2008 Jul; 102(2):242-4; author reply 244-8. PubMed ID: 18602529
    [No Abstract]   [Full Text] [Related]  

  • 18. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
    Hjelmesaeth J; Carlsson PO
    Lancet; 2002 Jun; 359(9324):2201-2; author reply 2203-4. PubMed ID: 12091007
    [No Abstract]   [Full Text] [Related]  

  • 19. [The unwanted effects of antihypertensive agents of the basic groups (2)].
    Metelitsa VI; Oganov RG
    Ter Arkh; 1997; 69(9):72-6. PubMed ID: 9411834
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factor assessment for new onset diabetes: literature review.
    Bakris G; Stockert J; Molitch M; Zhou Q; Champion A; Bacher P; Sowers J;
    Diabetes Obes Metab; 2009 Mar; 11(3):177-87. PubMed ID: 18564174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.